Trial Profile
LONG-TERM SURVEILLANCE STUDY OF LATANOPROST TO MONITOR HYPERPIGMENTATION CHANGES IN THE EYE IN PEDIATRIC POPULATIONS
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs Latanoprost (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Adverse reactions
- Sponsors Pfizer
- 18 Nov 2014 New trial record